Phase I/II trial of (131)I-MN-14F(ab)2 anti-carcinoembryonic antigen monoclonal antibody in the treatment of patients with metastatic medullary thyroid carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/10223579

Cancer 1999 Apr 15 85 8 1828-42

Download in:

View as

Triples

General Info

PMID
10223579